Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Jun;118(6):768-72.
doi: 10.1001/archopht.118.6.768.

Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis

Affiliations

Aqueous and serum interferon gamma, interleukin (IL) 2, IL-4, and IL-10 in patients with uveitis

M S Lacomba et al. Arch Ophthalmol. 2000 Jun.

Abstract

Objective: To determine the cytokine profile in aqueous humor and peripheral blood from patients with uveitis.

Methods: Cytokines (interferon [IFN]-gamma, interleukin [IL] 2, IL-4, and IL-10) were measured in aqueous humor and peripheral blood samples from 23 patients with uveitis and 16 patients undergoing operation for uncomplicated cataracts (control group) by means of an enzyme-linked immunosorbent assay.

Results: Aqueous and serum samples from patients with uveitis showed higher levels of IFN-gamma and IL-2 than those of controls (P<.001). Similarly, serum IL-10 levels were slightly higher in the uveitis group (P=.002). No differences were found between uveitis and control groups for aqueous and serum IL-4 or aqueous IL-10 levels. In patients with uveitis, IFN-gamma levels were significantly higher in serum than aqueous (P<.001), whereas IL-2 levels were higher in aqueous than in serum (P<.001). Serum IFN-gamma levels correlated with severe visual damage (r=0.44; P=. 03).

Conclusions: Aqueous and serum levels of IFN-gamma and IL-2 were elevated in patients with uveitis, suggesting a predominantly type 1 response (high IFN-gamma and low IL-4 levels). Elevated serum IFN-gamma level seems to predispose the patient to more serious loss of vision. Arch Ophthalmol. 2000;118:768-772

PubMed Disclaimer

Publication types